Recent advances in treatment of migraine.
作者信息
FRIEDMAN A P, VON STORCH T J C
出版信息
J Am Med Assoc. 1951 Apr 28;145(17):1325-8. doi: 10.1001/jama.1951.02920350019004.
Abstract
摘要
相似文献
1
Recent advances in treatment of migraine.
J Am Med Assoc. 1951 Apr 28;145(17):1325-8. doi: 10.1001/jama.1951.02920350019004.
2
Use of ergot preparations in migraine.
J Am Med Assoc. 1950 Aug 26;143(17):1462-4. doi: 10.1001/jama.1950.02910520004003.
3
The use of ergot-caffeine suppositories in migraine.
Med Ann Dist Columbia. 1950 Feb;19(2):77-9.
4
[Treatment of migraine by dihydroergotamine].
Paris Med. 1950 Nov 11;40(42):587-90.
5
The use of ergot drugs for migraine.
Med Ann Dist Columbia. 1952 Jul;21(7):372-5.
6
[The dihydroergotamine in the treatment of the migraine headache].
Belg Tijdschr Geneesk. 1948 Aug 1;4(15):721.
7
Further experience with dihydroergotamine methanesulfonate in the treatment of migraine; with a note on the use of cafergone.
Ann West Med Surg. 1949 Nov;3(11):388-90.
8
[Treatment of migraine and persistent headache with ergotamine tartrate and novocaine aerosols].
Presse Med (1893). 1950 Nov 29;58(76):1351-2.
9
[Effects of caffeinated ergotamine tartrate in migraine attacks; E. C. 110 or cafergon; first results].
J Med Chir Prat. 1950 Aug;121(8):165-9.
10
[Effects of caffeinated ergotamine tartrate in migraine attacks (E. C. 110 or cafergon); first results].
Lyon Med. 1950 May 28;183(22):345-8.
引用本文的文献
1
Central serous retinopathy.
Br J Ophthalmol. 1955 Oct;39(10):605-18. doi: 10.1136/bjo.39.10.605.
2
Pyschogenic factor in migraine.
Can Med Assoc J. 1952 Jul;67(1):23-5.
3
Effect of caffeine on intestinal absorption of ergotamine in man.
Eur J Clin Pharmacol. 1974;7(3):213-6. doi: 10.1007/BF00560383.
4
Buccal absorption of ergotamine.
J Neurol Neurosurg Psychiatry. 1974 Oct;37(10):1116-20. doi: 10.1136/jnnp.37.10.1116.
5
Clinical pharmacokinetics of ergotamine in migraine and cluster headache.
Clin Pharmacokinet. 1985 Jul-Aug;10(4):334-52. doi: 10.2165/00003088-198510040-00004.
Zotero 插件